We could suppose that decreased expression of SIRT1 affects the biogenesis process in SLE patients, blocking the mitochondrial turnover, and this leads to fewer vital mitochondria and increased ROS production. This evidence concerns the gene SIRT1 and systemic lupus erythematosus.